From April 1, 2022 to June 30, 2022, the company has repurchased 407,100 shares, representing 0.03% for CNY 19.1 million. With this, the company has completed the repurchase of 407,100 shares, representing 0.03% for CNY 19.1 million under the buyback announced on March 19, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.25 CNY | -0.28% | +4.17% | -39.39% |
Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
Apr. 03 | Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.39% | 3.15B | |
-2.71% | 87.37B | |
+4.08% | 41.01B | |
-25.35% | 28.08B | |
+54.31% | 24.72B | |
-4.52% | 17.47B | |
-42.09% | 11.69B | |
-17.77% | 11.6B | |
-12.10% | 11.56B | |
+0.75% | 8.44B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.